Currently out of the existing stock ratings of Roger Song, 27 are a BUY (75%), 8 are a HOLD (22.22%), 1 are a SELL (2.78%).

Roger Song

Work Performance Price Targets & Ratings Chart

Analyst Roger Song, currently employed at JEFFERIES, carries an average stock price target met ratio of 26.43% that have a potential upside of 18.88% achieved within 77 days.

Roger Song’s has documented 72 price targets and ratings displayed on 15 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on REPL, Replimune Group at 04-Dec-2024.

Wall Street Analyst Roger Song

Analyst best performing recommendations are on INO (INOVIO PHARMACEUTICALS).
The best stock recommendation documented was for INO (INOVIO PHARMACEUTICALS) at 11/10/2023. The price target of $4.8 was fulfilled within 6 days with a profit of $0.61 (14.56%) receiving and performance score of 24.26.

Average potential price target upside

BCEL Atreca REPL Replimune Group AADI Aadi Bioscience CRVS Corvus Pharmaceuticals CTMX CytomX Therapeutics GLYC GlycoMimetics KNTE Kinnate Biopharma  NKTR Nektar Therapeutics ACRS Aclaris Therapeutics ALT Altimmune NVAX Novavax IGMS IGM Biosciences FNCH Finch Therapeutics Group ICVX Icosavax INO Inovio Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1

$0.7 (233.33%)

$4

1 years 4 months 6 days ago
(14-Aug-2023)

0/6 (0%)

$0.49 (96.08%)

Hold

$1

$0.7 (233.33%)

$4

1 years 4 months 9 days ago
(11-Aug-2023)

0/6 (0%)

$0.44 (78.57%)

Buy

$25

1 years 4 months 10 days ago
(11-Aug-2023)

0/4 (0%)

$18.48 (1258.95%)

Buy

$20

1 years 8 months 19 days ago
(31-Mar-2023)

1/3 (33.33%)

$14.51 (264.30%)

220

Buy

$27

2 years 7 months 1 days ago
(19-May-2022)

0/1 (0%)

$18.23 (207.87%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Roger Song is most bullish on?

Potential upside of $6.45 has been obtained for REPL (REPLIMUNE GROUP)

Which stock is Roger Song is most reserved on?

Potential downside of -$0.91 has been obtained for AADI (AADI BIOSCIENCE)

What Year was the first public recommendation made by Roger Song?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?